The global Endoscopic Retrograde Cholangiopancreatography Market generated $134 million in 2020 and is expected to reach $156.5 million by 2028, with an annual average growth of 6% from 2021 to 2027.
The growth of the global Endoscopic Retrograde Cholangiopancreatography Market is mainly driven by the growth of the geriatric population. increased prevalence of dental diseases such as gum disease, cracked teeth and cavities; Increased demand for root canal treatment, increased investment in R&D activities of various healthcare companies.
A full report of Endoscopic Retrograde Cholangiopancreatography Market available at https://www.orionmarketreports.com/endoscopic-retrograde-cholangiopancreatography-market/55962/
Endoscopic Retrograde Cholangiopancreatography Market: Segmentation
By Product Type
• Endoscopes
• Endotherapy Devices
• Imaging Devices
• Energy Devices
• Others
By Application
• Biliary Sphincterotomy
• Biliary Dilatation
• Biliary Stenting
• Pancreatic Sphincterotomy
• Pancreatic Duct Dilatation
• Pancreatic Duct Stenting
By End User
• Hospitals & Clinics
• Ambulatory Surgery Centers
• Others
Key Market Competitors Covered in the Report
• Olympus Corporation
• CONMED Corporation
• Hobbs Medical
• TeleMed Systems, Inc
• Boston Scientific Corporation
• Cook
• Merit Medical Systems
• Jiangsu ATE Medical
• Karl Storz
• B. Braun Melsungen AG
• Ethicon
• BD
• Fujifilm Holding Corporation
• Medtronic Plc
• Johnson & Johnson Services, Inc
• Changzhou Health Microport Medical Device Co., LTD
• INTROMEDIC
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
